TY  - JOUR

T1  - Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force

JO  - Value in Health

UR  - http://dx.doi.org/10.1016/j.jval.2022.12.006

PY  - 2023/04/01

AU  - Tervonen T

AU  - Veldwijk J

AU  - Payne K

AU  - Ng X

AU  - Levitan B

AU  - Lackey LG

AU  - Marsh K

AU  - Thokala P

AU  - Pignatti F

AU  - Donnelly A

AU  - Ho M

ED  - 

DO  - DOI: 10.1016/j.jval.2022.12.006

PB  - Elsevier BV

VL  - 26

IS  - 4

SP  - 449

EP  - 460

Y2  - 2024/12/22

ER  -